Completed PHASE3 INTERVENTIONAL 2-arm NCT00432835

Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis

Double-Blind Placebo-Controlled Cross-Over Design With Wash-Out for Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis

Sponsor: Medtronic

Conditions Gastroparesis

Interventions Gastric Electrical Stimulator, Enterra, Medtronics, Inc.

Updated 7 times since 2017 Last updated: Nov 1, 2012 Started: Aug 31, 2005 Primary completion: Oct 31, 2006 Completion: Nov 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Gastroparesis, this trial is completed. The trial is conducted by Medtronic and has accumulated 7 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Dec 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Dec 2021 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Aug 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic
University of Mississippi Medical Center

Data source: University of Mississippi Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jackson, United States